MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0246247

Медицинская библиотека · PloS one · 2021

Metformin doses to ensure efficacy and safety in patients with reduced kidney function.

Kuan Isabelle H S, Wilson Luke C, Leishman Jed C, Cosgrove Samuel, Walker Robert J, Putt Tracey L, Schollum John B W, Wright Daniel F B

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

We aimed to develop a metformin dosing strategy to optimise efficacy and safety in patients with reduced kidney function. Metformin data from two studies stratified by kidney function were analysed. The relationship between metformin clearance and kidney function estimates was explored using a regression analysis. The maintenance dose range was predicted at different bands of kidney function to achieve an efficacy target of 1 mg/L for steady-state plasma concentrations. The dosing strategy was evaluated using simulations from a published metformin pharmacokinetic model to determine the probability of concentrations exceeding those associated with lactic acidosis risk, i.e. a steady-state average concentration of 3 mg/L and a maximum (peak) concentration of 5 mg/L. A strong relationship between metformin clearance and estimated kidney function using the Cockcroft and Gault (r2 = 0.699), MDRD (r2 = 0.717) and CKD-Epi (r2 = 0.735) equations was found. The probability of exceeding the safety targets for plasma metformin concentration was <5% for most doses and kidney function levels. The lower dose of 500 mg daily was required to maintain concentrations below the safety limits for patients with an eGFR of 15-29 mL/min. Our analysis suggests that a maximum daily dose of 2250, 1700, 1250, 1000, and 500 in patients with normal kidney function, CKD stage 2, 3a, 3b and 4, respectively, will provide a reasonable probability of achieving efficacy and safety. Our results support the cautious of use metformin at appropriate doses in patients with impaired kidney function.

Для цитирования: Kuan Isabelle H S, Wilson Luke C, Leishman Jed C, Cosgrove Samuel, Walker Robert J, Putt Tracey L, Schollum John B W, Wright Daniel F B. Metformin doses to ensure efficacy and safety in patients with reduced kidney function.. PloS one. 2021. DOI: 10.1371/journal.pone.0246247.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.